Leqembi® Iqlik™ (lecanemab-irmb) selected by TIME as one of the best innovations of 2025 ...Middle East

STOCKHOLM, Oct. 14, 2025 /PRNewswire/ -- BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai announced today that Leqembi Iqlik, a subcutaneous autoinjector formulation of lecanemab (generic name), for the treatment of Alzheimer's disease has been selected by TIME as one of the...

Hence then, the article about leqembi iqlik lecanemab irmb selected by time as one of the best innovations of 2025 was published today ( Tuesday 14/10/2025 - 08:17 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Leqembi® Iqlik™ (lecanemab-irmb) selected by TIME as one of the best innovations of 2025 )

Also on site :

• CNN Tests the Waters With a Creator-Driven Concept
• SAG-AFTRA Launches Verticals Agreement for Microdramas
• 98% of homes that used government insulation scheme need mould repairs